GlassScriptPhysician profile
Werner Jauch
NPI 1972595544
$1,603.28
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $929 · 2020: $349 · 2021: $325.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $264.05 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $236.56 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $210.09 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $209.92 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $192.37 | 2019 | |
| Amarin Pharma, INC. | $122.66 | 2019-2021 | |
| Ekos Corporation | $96.50 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $90.00 | 2020 | |
| Medtronic Vascular, INC. | $58.48 | 2019-2020 | |
| Boston Scientific Corporation | $40.64 | 2019 | |
| Amgen INC. | $23.58 | 2019 | |
| Zoll Circulation INC | $19.00 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $14.50 | 2020 | |
| Esperion Therapeutics, INC. | $13.55 | 2020 | |
| Braemar Manufacturing, LLC | $11.38 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Werner Jauch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.